Los Angeles County records some of California's highest Hepatitis C rates. While brand Harvoni offers a near-complete cure, its US list price exceeds $84,000 for a 12-week course — an impossible barrier for most uninsured patients.
Resof L contains the same Ledipasvir and Sofosbuvir combination, achieving SVR12 cure rates above 95% in Genotype 1 patients. The full 12-week course costs under $500 from a licensed Indian supplier — compared to $84,000+ for the brand.
Los Angeles hepatologists increasingly guide uninsured patients toward affordable Indian generics for HCV treatment.
❓ FAQ: How do I know generic Resof L is as effective as brand Harvoni?
Resof L uses the identical dual mechanism as brand Harvoni — Sofosbuvir inhibits the NS5B polymerase and Ledipasvir blocks the NS5A protein. Multiple peer-reviewed studies have confirmed SVR12 cure rates statistically equivalent to the original branded drug from WHO-GMP certified manufacturers.